Century Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Century Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 57% to $2,235,000. Profit margin reached -6115%. Total operating expenses were $148,781,000.

Profit Margin

Century Therapeutics, Inc. (NASDAQ:IPSC): Profit margin
2019 0 -245.97M
2020 0 -54.66M
2021 0 -95.82M
2022 5.19M -130.93M -2518.41%
2023 2.23M -136.67M -6115.12%

IPSC Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
2.23M5.19M000
Cost of revenue
13.04M10.07M4.58M1.75M249K
Gross profit
-10.80M-4.87M-4.58M-1.75M-249K
Operating exp.
Research and development
92.71M107.17M75.64M39.68M14.26M
Selling and marketing
00000
Total operating expenses
148.78M139.03M94.88M49.17M20.03M
Operating income
-146.54M-133.83M-94.88M-53.89M-245.97M
Other income (expenses), net
11.75M2.99M-898K323K1.21M
Income before tax
-134.79M-130.84M-95.78M-53.57M-244.76M
Income tax expense
1.88M91K43K1.08M1.21M
Net income
-136.67M-130.93M-95.82M-54.66M-245.97M
Earnings per share
Basic EPS
-2.3-2.27-1.74-1-4.49
Diluted EPS
-2.3-2.27-1.74-1-4.49
Data sourceData sourceData source